跳转至内容
Merck
CN
  • Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?

Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?

Diagnostic microbiology and infectious disease (2015-04-13)
Shahnaz Sali, Heidar Sharafi, Seyede Hoda Alavian, Seyed Moayed Alavian, Faranak Etesam, Shima Salimi, Muayad A Merza, Maryam Keshvari
摘要

Hepatitis B envelope antigen (HBeAg)-negative hepatitis B virus (HBV) infection exerts both inactive carrier (IC) state and chronic hepatitis B (CHB), which are sometimes difficult to be differentiated. We aimed to assess the role of hepatitis B surface antigen (HBsAg) level in differentiation of CHB and IC among a group of chronic HBeAg-negative HBV-infected patients. A total of 251 HBeAg-negative HBV-infected patients were enrolled. Serum HBV DNA and HBsAg levels were determined for each patient. HBV DNA quantification with cutoff value 2000IU/mL for diagnosis of CHB had 99.0% sensitivity and 74.1% specificity. A cutoff value of HBsAg level at 1000IU/mL was more reliable for diagnosis of CHB with 82.7% sensitivity and 66.2% specificity than other HBsAg cutoff values. There was a positive correlation between HBV DNA and HBsAg levels in both CHB (r=0.42, P<0.001) and IC (r=0.43, P<0.001) groups. Single-point HBsAg quantification did not have enough sensitivity and specificity for differentiation of HBeAg-negative CHB and IC state.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
胆红素, ≥98% (EmM/453 = 60), powder
Sigma-Aldrich
胆红素, purum, ≥95.0% (UV)